[ad_1]
Emma Spak, head of the section for health and medical care in the municipalities and regions of Sweden, SKR, agrees with the Prime Minister’s statement that it is the regions that are responsible for deficiencies when the elderly in nursing homes do not they have received the care they are entitled to.
However, he believes that the review carried out by the Swedish Health and Care Inspectorate, Ivo, needs to be expanded and notes that a smaller proportion of elderly care has been reviewed.
– The regions are responsible for The medical interventions in the care of the elderly and the review that Ivo has carried out is a risk-based analysis in which they analyzed a small sample, 98 out of 1,700 nursing homes. They have also been selected because they are suspected of having problems.
– But it is not that one in five older people does not receive adequate care. It is a misinterpretation, which has occurred in the debate, he says.
Ivo has assessed that one in five of the residents of these nursing homes have not received a medical evaluation even though they have a legal right to receive one.
But it’s a small selection and you need to go wider and see what it looks like, according to Emma Spak.
– This is something that the regions take very seriously, and will now go further to examine for themselves if it only applies to individual households or if there is any system in the neglect.
Stefan Löfven also says that The regions of Sweden have better conditions to vaccinate the entire population than other EU countries because they are used to vaccinating and because “we have one of the most vaccination-friendly populations”.
– The player with the greatest chance of being able to carry out a large-scale vaccination is undoubtedly the regions, says Emma Spak.
This year, regions have received two million doses to vaccinate against seasonal flu in the fall as part of regular activities.
– We are used to large-scale vaccinations against seasonal flu. But covid-19 vaccines require different and more complete logistics because it is an untested vaccine. It will be a major challenge for the regions.
That is why a collaboration has been started with not least the Swedish Public Health Agency, which will help, among other things, with the purchase of vaccines, information on handling and transport to the regions.
It is also necessary to agree on the distribution of the vaccine, which groups should be vaccinated first, and when it should be done.
– Close collaboration with the government and the Public Health Agency are the prerequisites for the regions to be able to manipulate their participation in the chain in a good way, says Emma Spak.
